Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study
Sign Up to like & getrecommendations! Published in 2021 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100350
Abstract: Background Preliminary analysis from Vax-On study did not find a correlation between cancer treatment type and antibody response to COVID-19 vaccination. We performed a secondary subgroup analysis to verify the effects of comprehensive cancer treatment… read more here.
Keywords: analysis; vaccine; treatment; timepoint ... See more keywords
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.704773
Abstract: Background Hemodialysis patients are at high risk for severe COVID-19. SARS-CoV-2 vaccination related safety and immunogenicity data in these patients are rare. Methods In this observational study SARS-CoV-2-seronegative hemodialysis patients were vaccinated with two doses… read more here.
Keywords: sars cov; mrna bnt162b2; hemodialysis patients; safety immunogenicity ... See more keywords
Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10060871
Abstract: Adolescents with underlying diseases are at risk of severe COVID-19. The immune response of BNT162b2 may be poor among immunocompromised adolescents. We aim to describe immunogenicity of mRNA BNT162b2 among adolescents who are immunocompromised or… read more here.
Keywords: adolescents chronic; immunity; group; mrna bnt162b2 ... See more keywords